We are live on
!
Find out more
SFG
SVB Financial Group Portfolio holdings
AUM
$434K
1-Year Est. Return
277.67%
This Fund
S&P 500
This Quarter
Est. Return
+6.69%
1 Year Est. Return
+277.67%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$53.2M
AUM Growth
+$251K
(+0.47%)
Cap. Flow
-$2.7M
Cap. Flow
% of AUM
-5.07%
Top 10 Holdings %
Top 10 Hldgs %
98.52%
Holding
24
New
–
Increased
1
Reduced
4
Closed
3
Avg Time Held
2.7
quarters
Top 10 Avg Time Held
2.1
quarters
Top 20 Avg Time Held
2.4
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Firy Inc
FIRY
|
+$2.25K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Okta
OKTA
|
+$1.57M |
| 2 |
DICE Therapeutics, Inc. Common Stock
DICE
|
+$1.01M |
| 3 |
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
|
+$65K |
| 4 |
Kalaris Therapeutics
KLRS
|
+$25.5K |
| 5 |
Generation Bio
GBIO
|
+$13.5K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 71.48% |
| 2 | Healthcare | 13.72% |
| 3 | Technology | 12.19% |
| 4 | Consumer Discretionary | 1.63% |
| 5 | Industrials | 0.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Coinbase
COIN
$47.6B
| $30.6M | 57.48% |
406,973
| – | – |
2022 Q4
3 quarters
|
|
2
Root
ROOT
$749M
| $7.45M | 14.01% |
783,012
| – | – |
2022 Q4
3 quarters
|
|
|
3
Okta
OKTA
$39.7B
| $6.45M | 12.14% |
79,152
-20,720
| -21% | -$1.57M |
2022 Q4
3 quarters
|
|
4
Axsome Therapeutics
AXSM
$8.7B
| $2.37M | 4.45% |
33,849
| – | – |
2022 Q4
3 quarters
|
|
5
Structure Therapeutics
GPCR
$1.71B
| $1.78M | 3.35% |
35,353
| – | – |
2023 Q1
2 quarters
|
|
6
Orchestra BioMed
OBIO
$355M
| $1.11M | 2.08% |
127,068
| – | – |
2023 Q1
2 quarters
|
|
7
MoonLake Immunotherapeutics
MLTX
$909M
| $922K | 1.73% |
16,173
| – | – |
2022 Q4
3 quarters
|
|
8
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $661K | 1.24% |
105,534
| – | – |
2022 Q4
3 quarters
|
|
9
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $636K | 1.2% |
10,000
| – | – |
2022 Q4
3 quarters
|
|
10
Planet Labs
PL
$5.81B
| $447K | 0.84% |
172,097
| – | – |
2022 Q4
3 quarters
|
|
11
Global E Online
GLBE
$6.55B
| $203K | 0.38% |
5,114
| – | – |
2023 Q2
1 quarter
|
|
12
Cullinan Oncology
CGEM
$962M
| $122K | 0.23% |
13,516
| – | – |
2022 Q4
3 quarters
|
|
13
Caribou Biosciences
CRBU
$53.3M
| $99K | 0.19% |
20,714
| – | – |
2022 Q4
3 quarters
|
|
|
14
DELISTED
Generation Bio
GBIO
| $94.9K | 0.18% |
2,503
-285
| -10% | -$13.5K |
2022 Q4
3 quarters
|
|
15
Pacific Biosciences
PACB
$653M
| $85.6K | 0.16% |
10,249
| – | – |
2022 Q4
3 quarters
|
|
|
16
Firy Inc
FIRY
$206M
| $71.1K | 0.13% |
13,950
+254
| +2% | +$2.25K |
2022 Q4
3 quarters
|
|
|
17
Kalaris Therapeutics
KLRS
$53.8M
| $37K | 0.07% |
748
-374
| -33% | -$25.5K |
2022 Q4
3 quarters
|
|
|
MVLA
18
DELISTED
Movella Holdings Inc. Common Stock
MVLA
| $29.8K | 0.06% |
55,528
| – | – |
2023 Q1
2 quarters
|
|
19
DELISTED
Venus Concept
VERO
| $20.9K | 0.04% |
970
| – | – |
2022 Q4
3 quarters
|
|
20
Eledon Pharmaceuticals
ELDN
$198M
| $18.5K | 0.03% |
13,472
-4,553
| -25% | -$6.08K |
2022 Q4
3 quarters
|
|
|
MKUL
21
DELISTED
Molekule Group, Inc. Common Stock
MKUL
| $3.08K | 0.01% |
21,247
| – | – |
2023 Q2
1 quarter
|
|
|
PRDS
22
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| – | – |
-35,923
| Closed | -$65K | – |
|
|
23
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| – | – |
-21,799
| Closed | -$1.01M | – |
|
|
GRNA
24
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
| – | – |
-16,950
| Closed | -$5.08K | – |
|
Similar funds
RCMC
CBFP
BP
SLA
SG
AFG
K
MIG
SVB Financial Group's Q3 2023 Portfolio in Review
As of Q3 2023, SVB Financial Group held 24 positions worth $53.2M, up 0.47% from $52.9M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
SVB Financial Group withdrew a net $2.7M in Q3 2023, closing 3 positions and reducing 4 holdings. Its most notable exit was DICE Therapeutics, Inc. Common Stock, an estimated $1.01M position sold in full.
By sector, the portfolio is most concentrated in Financials at 71% of assets, up from 68% a quarter earlier, followed by Healthcare and Technology.
Against the trend, SVB Financial Group added an estimated $2.25K to Firy Inc.
- SVB Financial Group added most to Firy Inc in Q3 2023, an estimated $2.25K increase.
- SVB Financial Group's biggest Q3 2023 reduction was Okta, cutting an estimated $1.57M.
- SVB Financial Group fully exited DICE Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $1.01M.
- SVB Financial Group's ten largest holdings make up 99% of its $53.2M portfolio in Q3 2023.
- SVB Financial Group opened 0 new positions and closed 3 in Q3 2023.
- SVB Financial Group's portfolio value rose 0.47% quarter-over-quarter to $53.2M.
Based on SVB Financial Group's 13F filing for Q3 2023, filed 14 Nov 2023.